The administration of adipose tissue-derived stem cells after the onset of necrotizing enterocolitis did not reduce the levels of inflammatory cytokines IL-1 and IL-6, nor did it influence the histopathological outcomes of the disease in a rat model of NEC. This evidence concerns the gene IL1B and necrotizing enterocolitis.